Wittenberg Investment Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Wittenberg Investment Management's MRNA Position: Q2 2026 in Review
Wittenberg Investment Management reduced its Moderna (MRNA) stake by 3% in Q2 2026, selling an estimated $51.7K and leaving 32,500 shares worth $2.28M. The position accounts for 0.78% of the portfolio, ranked #23.
Wittenberg Investment Management first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Wittenberg Investment Management held 32,500 shares of Moderna worth $2.28M as of Q2 2026.
- Wittenberg Investment Management sold 1,000 Moderna shares in Q2 2026, an estimated $51.7K.
- Moderna made up 0.78% of Wittenberg Investment Management's portfolio in Q2 2026, its #23 holding.
- Wittenberg Investment Management first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Wittenberg Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.